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Abstract
Pharmacokinetic analysis of the distribution and concentration of adriamycin (ADM) in mouse
plasma and tissues was carried out by differentiating the unmetabolized form from metabolized
ones using high-performance liquid chromatography after a single intravenous injection. Marked
differences between ADM and total ADM equivalent values (total ADM values) or its metabolized
forms were observed in the pharmacokinetic behavior in plasma and tissue distributions. The ra-
tios of tissue per plasma for total ADM and for ADM values in the liver, kidney and heart showed
a two-digit magnitude each time they were examined. Twenty four h later, the ratios for ADM
values in the liver, kidney, heart and lung were at high levels; 43.1, 48.1, 57.9 and 45.5 times,
respectively. Twenty min after injection the ratios for total ADM values in the spleen, lung and
tumors were comparatively small, but 24 h later, the ratio had increased 36.5, 45.5 and 6.8 times
respectively.
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